We chose to focus our studies on Mettl7a1, one of the candidate direct transcriptional targets of EPR (2), since our meta-analysis of publicly available proteomic datasets showed that human METTL7A is downregulated in breast cancer as well as in several other cancers (Supplementary Figure S1A). The gene discussed is TMT1A; the disease is breast cancer.